Have you seen those "educational" editions of Microsoft Corp. (NASDAQ: MSFT)'s software for sale at your favorite local retailer? These "Student" editions are deeply discounted and are meant for ... students and educational professionals. Some iffy retailers, though, buy these copies from nefarious sources who have purchased the software already at a discount and are pawning it off as the "regular" product to internet retailers. The victim becomes the end-customer, who receives a product without all the features present, since what they have bought is an "educational" edition.
This practice has gone on worldwide and Microsoft continually has policed these activities. In the latest, the software company said this week that it will be taking action against groups that sold copies of Windows and Office discounted for academic use to regular users. In general, more software piracy against Microsoft goes on outside the U.S. (China is a big offender), and this case is no different. Ole' Softie processed nine lawsuits and sent more than 50 letters threatening legal action against groups that operate internationally (some posing as academic resellers in Jordan). The suits were filed in the U.S., however.
The problem is that these "resellers" bought the licenses cheaper than normal versions of the software, which in turn sold the academic products to U.S. resellers (at a discount), who then made heftier margins charging customers full retail (non-academic) prices. Of course, end-customers are not educators (usually), so these unsuspecting consumers ended up with a piece of software that was not licensed to be used in the home (or office). PC software piracy has gotten better with the advent of license checks on PCs over the internet, but where there's illegitimate money to be made, someone will be making it, right?
Last updated: February 10, 2012: 05:56 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Greek cabinet approves new austerity plan, will vote on Sunday, CNBC reports
- CBOE Holdings to be added to S&P 400; Temple-Inland deleted as of 2/13 close
- Mylan announces unfavorable verdict in patent trial
- NYSE market internals summary
- NASDAQ market internals summary
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

